Crossmark

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?

Crossref DOI link: https://doi.org/10.1186/s13613-019-0512-0

Published Online: 2019-03-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Honore, Patrick M.

De Bels, David

Redant, Sebastien

Spapen, Herbert D.
License Information

Text and Data Mining valid from 2019-03-08
More Information

Article History

Received: 11 February 2019

Accepted: 4 March 2019

First Online: 8 March 2019